O. Jourdain et al., BREAST-CANCER AND IN-VITRO FERTILIZATION - ABOUT 32 CASES, European journal of obstetrics, gynecology, and reproductive biology, 67(1), 1996, pp. 47-52
Because of the increased risk of breast cancer for infertile nulliparo
us women, the suspected promoter role of estradiol in mammary carcinog
enesis and the high frequency of ovulation inducer treatments, it was
interesting to focus on the risk of breast cancer after such a treatme
nt. We reviewed 32 cases during a retrospective survey in Assisted Rep
roductive Techniques (ART) centers in France. Because of the small sam
ple size and the few cases published so far, no statistical study coul
d be made. However, many observations may have gone unnoticed or were
not published. Two hypotheses can be proposed: (1) the facilitating ro
le of stimulation on potential infra-clinical or un-diagnosed cancers;
(2) the initiation of new cancers. Consequently, we propose to establ
ish a register for the follow-up of treated women to monitor the adven
t of new cancers and to increase the follow-up of patients with other
associated risk factors.